CorFlow Therapeutics AG today announced that Mrs. Esther Gerteis has been appointed CorFlow's VP Medical Affairs and will be a member of [...]
CorFlow Therapeutics AG today announced that the company has completed the CHF 2.6M 1st close of its Seed+ financing round led by [...]
CorFlow Therapeutics AG today announced that its ISO 13485:2016 compliant Quality Management System (QMS) has been certified by the British Standards Institution (BSI).
The MedTech Strategist has published a review article in it's current issue of CorFlow Therapeutics AG and CorFlow's Controlled Flow Infusion (CoFITM) [...]
ReFlow Therapeutics AG ("ReFlow") today announced that the Company has been awarded a Swiss non-dilutive public grant from the Swiss Commission for [...]
ReFlow Therapeutics AG ("ReFlow") today announced that the Company closed it's oversubscribed seed financing round raising an undisclosed single digit million Swiss Francs amount. ReFlow is [...]